Adalimumab-bwwd
- Product NDC
- 83457-186
- 11-digit product format
- 834570186
- Labeler code
- 83457
- Product ID
- 83457-186_62d117b6-ce78-4e27-9599-fcde5bc476db
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- adalimumab-bwwd
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Cordavis Limited
- Application
- BLA761059
- Marketing category
- BLA
- Marketing start
- 2025-12-12
- Substance
- ADALIMUMAB
- Active strength
- 40 mg/.4mL
- Pharmacologic classes
- Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Adalimumab-bwwd
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ADALIMUMAB | 40 mg/.4mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | FYS6T7F842 |
| Rxcui | 2640425, 2640430 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 83457-186-01 | Adalimumab-bwwd | 2 in 1 CARTON | SOLUTION | 2 | | 2 |
| 83457-186-99 | Adalimumab-bwwd | 0.4 mL in 1 SYRINGE | SOLUTION | 0.4 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 83457-186-01 | 83457018601 | 2 SYRINGE in 1 CARTON (83457-186-01) / .4 mL in 1 SYRINGE (83457-186-99) | 2 syringe | 2025-12-12 | No | No | Historical |
| 83457-186-99 | 83457018699 | 0.4 mL in 1 SYRINGE | 0.4 ml | | | | Historical |